- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05720806
Weight Bearing Status Post-hip Arthroscopy
Weight Bearing as Tolerated (WBAT) Following Hip Arthroscopic Labral Repair and Femoroplasty.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15238
- UPMC Hip Preservation Program
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age>= 12 years
- Diagnoses: femoroacetabular impingement and hip labral tears.
- Surgical procedures performed: Hip arthroscopy with femoroplasty and labral repair.
- Surgery completed at UPMC Children's or UPMC St. Margaret's Hospital
- unilateral and bilateral hip patients
Exclusion Criteria:
- MSK tumor-related FAI or dysplasia
- generalized hypermobility
- revision surgeries
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Weight bearing as tolerated (WBAT) immediately following surgery.
Subjects will be able to self-select weight bearing based on pain and confidence in surgical hip.
|
Subject will be provided standard of care physical therapy following surgical intervention, except will be able to self-select weight bearing based on pain and confidence.
|
Active Comparator: Flat foot weight bearing (FFWB) for 2 weeks after surgery.
Subjects will be limited to FFWB, approx 20lbs through the surgical hip.
|
Subject will be provided standard of care physcial therapy following surgical intervention except
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
International Hip Outcome Tool 12 (iHot-12)
Time Frame: up to 6 months post-operative
|
Scoring ranges from 0-100
|
up to 6 months post-operative
|
Hip and Groin Outcome Score (HAGOS)
Time Frame: up to 6 months post-operative
|
This outcome includes 6 subscales, these are scored independently, and no aggregate scoring is calculated as each section assesses different dimensions separately. Subscales (raw scores for each subscale converted to a 0-100 scale with higher score indicating higher level of function):
|
up to 6 months post-operative
|
Hip Outcome Score (HOS) ADL
Time Frame: up to 6 months post-operative
|
Outcome assessing function with activities of daily living. Higher score is given for higher level of function and lower score indicating reduced function. 0-68 aggregate scoring converted to 0-100 scale. |
up to 6 months post-operative
|
Hip Outcome Score (HOS) Sport
Time Frame: up to 6 months post-operative
|
Outcome assessing function/difficulty completing dynamic activities associated with sports participation. Higher score is given for higher level of function and lower score indicating reduced function. 0-36 aggregate scoring converted to 0-100 scale. |
up to 6 months post-operative
|
Tampa Scale for Kinesiophobia-11
Time Frame: up to 6 months post-operative
|
Outcome measure assessing fear of pain with movement.
Scores range from 11 to 44.
Higher scores indicate greater fear of movement
|
up to 6 months post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Isometric strength measures hip add, abd, ER, and extension
Time Frame: 6-week, 3 months, and 6-month post-operative
|
Strength measures will be taken isometrically at post-operative follow ups.
|
6-week, 3 months, and 6-month post-operative
|
Diagnostic ultrasound assessment of bilateral anterior hip capsule thickness
Time Frame: 3 months post-operative
|
Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing. Ultrasound will measure the following: 1.Assess the bilateral hip anterior capsule in all patients, assessing for internal consistency or changes in capsular thickness from side to side. Normal hip capsular thickness has been reported as 7-8 mm, dysplastic hips range 3.2 +/- 0.5 mm, and femoroacetabular impingement subjects 4.7 +/- 0.6 mm. |
3 months post-operative
|
Diagnostic ultrasound assessment of incision widening
Time Frame: 3 months post-operative
|
Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing. 1. Evaluation of capsular incision widening, cyst, attenuation and thinning from established norms. Normal hip capsular thickness has been reported as 7-8 mm, dysplastic hips range 3.2 +/- 0.5 mm, and femoroacetabular impingement subjects 4.7 +/- 0.6 mm |
3 months post-operative
|
Diagnostic ultrasound for focal echogenic adhesions
Time Frame: 3 months post-operative
|
Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing. 1. Evaluate for focal echogenic adhesions or dyskinetic motion between capsule and overlying iliopsoas complex with activation of hip flexion. |
3 months post-operative
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- STUDY22080053
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acetabular Labral Tear
-
Ain Shams UniversityNot yet recruitingHip Injuries | Femoro Acetabular Impingement | Acetabular Labral TearEgypt
-
Peking University Third HospitalEnrolling by invitationFemoroacetabular Impingement | Acetabular Labral TearChina
-
Smith & Nephew, Inc.Active, not recruitingAcetabular Labrum Tear | SLAP Lesion | Bankart Lesions | Rotator Cuff Tears | Labral Tear, Glenoid | Anterior Shoulder InstabilityUnited States
-
University of WashingtonNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Active, not recruitingAcetabular Labral Tear | Femoroacetabular Impingement SyndromeUnited States
-
Rush University Medical CenterRecruitingLabral Tear, Glenoid | Femoral Acetabular ImpingementUnited States
-
Ohio State UniversityCompletedPain, Postoperative | Femoro Acetabular Impingement | Hip Labral TearUnited States
-
Rush University Medical CenterRecruitingPain | Opioid Use | Labral Tear, Glenoid | Femoral Acetabular ImpingementUnited States
-
University of OxfordArthritis Research UK; The Royal College of Surgeons of EnglandUnknownAcetabular Labrum TearUnited Kingdom
-
Peking University Third HospitalCompletedAcetabular Labrum TearChina
-
Revalesio CorporationWithdrawn
Clinical Trials on Weight Bearing as tolerated (WBAT) immediately following surgery.
-
Panam ClinicRecruitingFemoro Acetabular ImpingementCanada
-
Nova Scotia Health AuthorityRecruitingOsteochondritis Dissecans of Ankle and Joints of FootCanada
-
Slagelse HospitalCompletedSurgery--Complications | Early Ambulation | Tibia FractureDenmark
-
Assiut UniversityTexas Tech University Health Sciences CenterRecruitingFracture of Tibia Proximal PlateauEgypt